A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy

PURPOSE: To evaluate the toxicity, pharmacological, and biological properties of the combination of bortezomib, etoposide, and carboplatin in adults with advanced solid malignancies. PATIENTS AND METHODS: Patients received escalating doses of bortezomib, etoposide, and carboplatin every 21 days. Sur...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lieu, Christopher, Chow, Laura, Pierson, A. Scott, Eckhardt, S. Gail, O'Bryant, Cindy L., Morrow, Mark, Tran, Zung Vu, Wright, John J., Gore, Lia
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2829404/
https://ncbi.nlm.nih.gov/pubmed/18618082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-008-9154-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak